Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Acquired by SG Americas Securities LLC

SG Americas Securities LLC boosted its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 18.8% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 5,996 shares of the company’s stock after buying an additional 947 shares during the quarter. SG Americas Securities LLC’s holdings in Prestige Consumer Healthcare were worth $468,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of PBH. JPMorgan Chase & Co. increased its position in shares of Prestige Consumer Healthcare by 3.2% during the third quarter. JPMorgan Chase & Co. now owns 272,255 shares of the company’s stock worth $19,630,000 after purchasing an additional 8,533 shares in the last quarter. Geode Capital Management LLC grew its stake in Prestige Consumer Healthcare by 4.0% during the 3rd quarter. Geode Capital Management LLC now owns 1,326,794 shares of the company’s stock valued at $95,678,000 after acquiring an additional 50,961 shares in the last quarter. Sequoia Financial Advisors LLC raised its holdings in Prestige Consumer Healthcare by 12.9% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 9,824 shares of the company’s stock valued at $708,000 after acquiring an additional 1,120 shares during the last quarter. Barclays PLC lifted its stake in Prestige Consumer Healthcare by 346.3% in the 3rd quarter. Barclays PLC now owns 92,444 shares of the company’s stock worth $6,665,000 after purchasing an additional 71,730 shares in the last quarter. Finally, Assenagon Asset Management S.A. grew its position in shares of Prestige Consumer Healthcare by 171.6% in the fourth quarter. Assenagon Asset Management S.A. now owns 46,931 shares of the company’s stock valued at $3,665,000 after purchasing an additional 29,649 shares in the last quarter. 99.95% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research firms have weighed in on PBH. DA Davidson reissued a “buy” rating and set a $95.00 price objective on shares of Prestige Consumer Healthcare in a research note on Monday, November 11th. Sidoti lowered shares of Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 price target on the stock. in a research report on Monday, December 9th. Raymond James upgraded Prestige Consumer Healthcare to a “moderate buy” rating in a report on Thursday, December 19th. Finally, StockNews.com upgraded shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a report on Friday, January 24th. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $85.25.

Insider Activity

In related news, insider William P’pool sold 8,987 shares of Prestige Consumer Healthcare stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $81.85, for a total transaction of $735,585.95. Following the completion of the transaction, the insider now directly owns 20,058 shares of the company’s stock, valued at approximately $1,641,747.30. The trade was a 30.94 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Ronald M. Lombardi sold 10,875 shares of Prestige Consumer Healthcare stock in a transaction dated Tuesday, November 19th. The stock was sold at an average price of $82.60, for a total transaction of $898,275.00. Following the transaction, the chief executive officer now owns 320,952 shares of the company’s stock, valued at approximately $26,510,635.20. The trade was a 3.28 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 38,810 shares of company stock valued at $3,187,300. 1.60% of the stock is currently owned by company insiders.

Prestige Consumer Healthcare Stock Down 2.1 %

Shares of NYSE PBH opened at $76.74 on Friday. The business’s fifty day simple moving average is $79.63 and its 200-day simple moving average is $75.17. The stock has a market cap of $3.79 billion, a P/E ratio of 18.67, a PEG ratio of 2.21 and a beta of 0.51. Prestige Consumer Healthcare Inc. has a 12-month low of $60.00 and a 12-month high of $86.36. The company has a current ratio of 3.56, a quick ratio of 2.10 and a debt-to-equity ratio of 0.61.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings results on Thursday, November 7th. The company reported $1.09 EPS for the quarter, meeting the consensus estimate of $1.09. Prestige Consumer Healthcare had a net margin of 18.54% and a return on equity of 12.23%. The company had revenue of $283.79 million for the quarter, compared to analyst estimates of $282.09 million. During the same period in the prior year, the firm posted $1.07 earnings per share. The firm’s revenue was down .9% on a year-over-year basis. As a group, equities analysts predict that Prestige Consumer Healthcare Inc. will post 4.46 EPS for the current fiscal year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.